N-Acetylaspartylglutamate in CNS Hypomyelination

Abstract

CSF N-acetylaspartylglutamate (NAAG) has been found to be elevated in some hypomyelinating disorders. This study addressed the question whether it could be used as a marker for hypomyelination and as a means to distinguish between hypomyelinating disorders biochemically. We have measured CSF NAAG in a cohort of 28 patients with hypomyelination with known and unknown aetiology. NAAG was found to be elevated in 7 patients, but was normal in the majority, including patients with defined hypomyelinating disorders. CSF NAAG is not a universal marker of hypomyelination, and the mechanism of its elevation remains poorly understood.

Key words

N-acetylaspartylglutamate - hypomyelination - white matter disorder

References

• 1 Ariyannur PS, Moffett JR, Manickam P. et al . Methamphetamine-induced neuronal protein NAT8L is the NAA biosynthetic enzyme: implications for specialized acetyl coenzyme A metabolism in the CNS.  Brain Res. 2010;  1335 1-13
• 2 Baslow MH. Evidence that the tri-cellular metabolism of N-acetylaspartate functions as the brain's “operating system”: how NAA metabolism supports meaningful intercellular frequency-encoded communications.  Amino Acids. 2010;  39 1139-1145
• 3 Burlina AP, Ferrari V, Burlina AB. et al . N-Acetylaspartylglutamate (NAAG) in Pelizaeus-Merzbacher disease.  Adv Exp Med Biol. 2006;  576 353-359 ; discussion 353–361
• 4 Burri R, Steffen C, Herschkowitz N. N-Acetyl-L-aspartate is a major source of acetyl groups for lipid synthesis during rat brain development.  Dev Neurosci. 1991;  13 403-411
• 5 Kolodziejczyk K, Hamilton NB, Wade A. et al . The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes.  Brain. 2009;  132 1496-1508
• 6 Chakraborty G, Mekala P, Yahya D. et al . Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase.  J Neurochem. 2001;  78 736-745
• 7 Madhavarao CN, Arun P, Moffett JR. et al . Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease.  Proc Natl Acad Sci USA. 2005;  102 5221-5226
• 8 Mehta V, Namboodiri MA. N-Acetylaspartate as an acetyl source in the nervous system.  Brain Res Mol Brain Res. 1995;  31 151-157
• 9 Mochel F, Boildieu N, Barritault J. et al . Elevated CSF N-acetylaspartylglutamate suggests specific molecular diagnostic abnormalities in patients with white matter diseases.  Biochim Biophys Acta. 2010;  1802 1112-1117
• 10 Mochel F, Engelke UF, Barritault J. et al . Elevated CSF N-acetylaspartylglutamate in patients with free sialic acid storage diseases.  Neurology. 2010;  74 302-305
• 11 Sartori S, Burlina AB, Salviati L. et al . Increased level of N-acetylaspartylglutamate (NAAG) in the CSF of a patient with Pelizaeus-Merzbacher-like disease due to mutation in the GJA12 gene.  Eur J Paediatr Neurol. 2008;  12 348-350
• 12 Steenweg ME, Vanderver A, Blaser S. et al . Magnetic resonance imaging pattern recognition in hypomyelinating disorders.  Brain. 2010;  133 2971-2982
• 13 Wolf NI, Harting I, Boltshauser E. et al . Leukoencephalopathy with ataxia, hypodontia, and hypomyelination.  Neurology. 2005;  64 1461-1464
• 14 Wolf NI, Willemsen MA, Engelke UF. et al . Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF.  Neurology. 2004;  62 1503-1508
• 15 Zara F, Biancheri R, Bruno C. et al . Deficiency of hyccin, a newly identified membrane protein, causes hypomyelination and congenital cataract.  Nat Gen. 2006;  38 1111-1113

Correspondence